Patents by Inventor Abed Zeibdawi

Abed Zeibdawi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Amino acid-substituted coagulation factor V
    Patent number: 7666990
    Abstract: There is provided FV derivatives that reduce blood clotting activity, by reducing thrombin generation, when compared to wild-type FV. In particular, the FV of the present invention comprises single-point and multi-point mutations, encompassed by aspartic acid 79 to glutamic acid 119 of the wild type sequence (SEQ ID NO:2). The derivatives can be used to treat patient with conditions necessitating reduced clotting activity.
    Type: Grant
    Filed: January 23, 2006
    Date of Patent: February 23, 2010
    Assignee: Canadian Blood Services
    Inventors: Edward L. G. Pryzdial, Abed Zeibdawi, Jean Grundy
  • Amino acid-substituted coagulation factor V
    Publication number: 20060241039
    Abstract: There is provided FV derivatives that reduce blood clotting activity, by reducing thrombin generation, when compared to wild-type FV. In particular, the FV of the present invention comprises single-point and multi-point mutations, encompassed by aspartic acid 79 to glutamic acid 119. The derivatives can be used to treat patient with conditions necessitating reduced clotting activity.
    Type: Application
    Filed: January 23, 2006
    Publication date: October 26, 2006
    Applicant: Canadian Blood Services
    Inventors: Edward Pryzdial, Abed Zeibdawi, Jean Grundy